Aurobindo Pharma’s Telangana API Unit Gets Five FDA Observations

Aurobindo Pharma Ltd. said late Friday that the US Food and Drug Administration has issued five observations to its wholly owned subsidiary Apitoria Pharma Pvt. Ltd.’s facility in Telangana.

The unit, which manufactures active pharmaceutical ingredients, was inspected by the US regulator between August 21 and Friday, the company said in an exchange filing.